Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antipsychotic-induced movement disorders: evaluation and treatment.

Literature DB >> 21179628

Antipsychotic-induced movement disorders: evaluation and treatment.

Maju Mathews¹, Sylvia Gratz, Babatunde Adetunji, Vinu George, Manu Mathews, Biju Basil.

Abstract

Entities: Disease

Year: 2005 PMID： 21179628 PMCID： PMC3004713

Source DB: PubMed Journal: Psychiatry (Edgmont) ISSN： 1550-5952

× No keyword cloud information.

43 in total

Review 1. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics.

Authors: T R Barnes; M A McPhillips
Journal: Br J Psychiatry Suppl Date: 1999

2. Intravenous biperiden in akathisia: an open pilot study.

Authors: S Hirose; C R Ashby
Journal: Int J Psychiatry Med Date: 2000 Impact factor: 1.210

3. Incidence of tardive dyskinesia: five-year data from a prospective study.

Authors: J M Kane; M Woerner; P Weinhold; J Wegner; B Kinon
Journal: Psychopharmacol Bull Date: 1984

4. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.

Authors: K Alptekin; B B Kivircik
Journal: Int Clin Psychopharmacol Date: 2002-09 Impact factor: 1.659

5. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.

Authors: Mary Ann Richardson; Margaret L Bevans; Laura L Read; Helen M Chao; James D Clelland; Raymond F Suckow; Timothy J Maher; Leslie Citrome
Journal: Am J Psychiatry Date: 2003-06 Impact factor: 18.112

6. Clonidine in neuroleptic-induced akathisia.

Authors: L A Adler; B Angrist; E Peselow; J Reitano; J Rotrosen
Journal: Am J Psychiatry Date: 1987-02 Impact factor: 18.112

7. Use of clonidine in treating neuroleptic-induced akathisia.

Authors: G S Zubenko; B M Cohen; J F Lipinski; J M Jonas
Journal: Psychiatry Res Date: 1984-11 Impact factor: 3.222

8. Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.

Authors: M Raja
Journal: Eur Arch Psychiatry Clin Neurosci Date: 1995 Impact factor: 5.270

9. Akathisia with haloperidol and thiothixene.

Authors: T Van Putten; P R May; S R Marder
Journal: Arch Gen Psychiatry Date: 1984-11

10. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia.

Authors: S M Halstead; T R Barnes; J C Speller
Journal: Br J Psychiatry Date: 1994-02 Impact factor: 9.319

15 in total

Review 1. Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors: Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal: Ochsner J Date: 2017

2. Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.

Authors: Yu-Jung Wei; Xinyue Liu; Nikhil Rao; Marie McPherson; Mary Beth Jones; Regina Bussing; Almut G Winterstein
Journal: J Child Adolesc Psychopharmacol Date: 2017-07-14 Impact factor: 2.576

Review 3. Classics in Chemical Neuroscience: Aripiprazole.

Authors: Austen B Casey; Clinton E Canal
Journal: ACS Chem Neurosci Date: 2017-04-13 Impact factor: 4.418

4. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.

Authors: Maria Juncal-Ruiz; Mariluz Ramirez-Bonilla; Jorge Gomez-Arnau; Victor Ortiz-Garcia de la Foz; Paula Suarez-Pinilla; Obdulia Martinez-Garcia; Karl David Neergaard; Rafael Tabares-Seisdedos; Benedicto Crespo-Facorro
Journal: Psychopharmacology (Berl) Date: 2017-05-31 Impact factor: 4.530

10. Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.

Authors: Stanley N Caroff; Fan Mu; Rajeev Ayyagari; Traci Schilling; Victor Abler; Benjamin Carroll
Journal: BMC Psychiatry Date: 2020-07-11 Impact factor: 3.630